Huge Huge Huge Huge Post With NEW Information (HHHHPWNI

New Post Public Reply Private Reply Replies (5) Message Board
joey68
Huge Huge Huge Huge Post With NEW Information
(HHHHPWNI for short)
Did I mention this stuff is HUGE?

Note :
The links in this post may only work from the original board it was written.

I bet the majority of investors have never seen this stuff before!
I was doing some DD and surprisingly came across new stuff I never found before.

To start, I found the manual for the wavstat4. I cant wait to see the updated version of the manual!

Heres the English version of the manual:
http://www.spectrascience.com/images/uploads/..._Rev_B.pdf

Great read, and guess what? For the first time that ive ever seen (because we’ve heard of it, but how many people have actually seen it).. the manual shows the CE Mark on Page 2.

The actual CE mark is called ‘CE 0459’ which is standard. Perfect!

The manual even shows the BACK of the WavSTAT4 on page 10!

Reading through this manual, I google searched some key words and boom! Pow! Zing! All this new DD started slapping me in the face. I have a frozen bag of peas on my eye to help with the swelling.

Anyways..
Above the CE mark, it says ‘ EMERGO EUROPE’ .

Going to the EMERGO group website:
http://www.emergogroup.com/services/europe/ne...mbursement

it talks about Europe’s reimbursement programs. If you don’t know what this is, do some DD and youll figure it out.

Anyways.. EMERGOs site says:
Quote:

The Dutch medical device reimbursement process involves a diagnosis-related group (DRG) system known as the DBC used for patient classification and cost containment, as well as health technology assessments ( HTAs ) to determine cost-effectiveness of treatments.


Notice it mentions HTAs.

I googled "HTA" "spectrascience" and up pops this website:


http://deviceaccess.co.uk/

On the website, if you scroll down and watch the first video titled, “ Market Access & Reimbursement ”…

check out the speaker at :30 seconds! Its Hughes Wielemans of Spectrascience! In the video, he says SCIE is very interested in being adopted in the UK. Well, just listen to the video and hear it for yourself.

Did you hear Hughes say he asked Michael Branagan-Harris how to enter the UK market?

Michael Branagan-Harris Linkedin:
https://uk.linkedin.com/in/michael-branagan-harris-7b4a938

Quote:
“CEO Device Access UK Ltd-Market Access & Reimbursement Consultancy for MedTech & Diagnostic Devices into NHS England”


Hes the CEO of Device Access! Now scroll down to the bottom of the device access website, and look at their Client list!

Spectrascience is a client of theirs!! Do you see it? Its right there in PLAIN SIGHT! Im seriously not making this stuff up. Spectrascience is utilizing Device Access’s resources to penetrate the UK Market . And what does this mean? It means Spectrascience has been ACTIVELY working on entering the UK MARKET since 2014!

And remember, that video is from 2014 which means as of this post, we are 2 YEARS ahead of when this video was published.


Now go to 3:36 seconds in the video and hear him talk again. This is the best part!

He says that SCIE tried to enter the market on their own in the past and it made them lose 1 and a half years. Although this may sound bad, it’s not. It shows very typical growing pains. It’s very common for companies to try to save money by ‘doing things on their own’ only to figure out they need outside help. (..like you’ve never tried to do something on youre own, only to later realize you needed help. I know I have.)

This shows me that, instead of CONTINUING to try to do it on their own, SCIE admitted they needed help, and sought professional assistance from Device Access. This is great because it shows SCIE’s management was willing to admit they needed assistance.

MANY companies die off because they refuse to seek outside assistance. But not SCIE! Now they have the assistance of Device Access and again, seeing this video was from 2014, more than likely, they are 2 years closer to being marketable in the UK. This also helps build ‘good debt’. I talked about this in a previous post. ‘Good debt’ stems from the saying ‘it takes money to make money’. Any money SCIE spent on Device Access is going towards future profits. EXCELLENT!


BOOM! Even MORE proof Spectrascience hasn’t been sitting on their rump doing nothing for the past several years. Like I said a thousand times, it can take YEARS to penetrate the medical market in order to get your product developed, tested, approved, marketed, and distributed. And now, the majority of this stuff is in the PAST and whats the logical next step??

SALES!

In this 10K? Who knows! But who cares! Sales should be coming regardless of whether or not they show up in this 10K or the next 10Q or the next 10Q after that. As a long investor, it doesn’t matter to me because until I see evidence that this company is going to fail, im not going anywhere. Every corner I turn, I keep finding more and more evidence of a probable success story for Spectrascience, and now the story unfolds even more knowing SCIE has been actively working on selling their product in the UK with Device Access.

DD strikes again. DD:43 / Naysayers: 0

Note
Any blubbering response from naysayers which do not include links clearly stating SCIE is not working on penetrating the UK market will be ignored (you won’t find any).

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Job Market Shifts: Adaptation vs. Fairness Dilemma

Updated Category News Views 2

The Chameleon Effect in Today's Job Market Walk into any open-space office these days, and you'll see faces plastered with composed, work-ready smiles—faces that might not look so familiar outside those walls. The modern workplace has draped its cloak over individual personalities, with the mighty pressure to 'fit in' often forcing a change in how folks present...

Continue Reading
Wave Kids™ Unveils New Flavors for Kids' Drinks

Updated Category News Views 1

Sparking a Fresh Wave in the Kids' Beverage Market Alright, let me tell you about a new player plowing into the kids' drink scene. Wave Kids™, a brand that's making waves—pun intended—has a fresh lineup that screams 'fun' and 'healthy' in equal measure. Just coinciding with back-to-school season, this Scottsdale, Arizona outfit has rolled out not one or two, but...

Continue Reading
LeoLabs and SciTec Partner for $93.7M Space Force Deal

Updated Category News Views 1

LeoLabs and SciTec Join Forces for Space Dominance The space race ain't just about rockets blasting off anymore. It's about making sure we've got eyes everywhere, even on the back of our heads, so to speak. Enter LeoLabs teaming up with SciTec to help the U.S. Space Force upgrade their radar systems to something out of a sci-fi flick, armed with a $93.7 million contract...

Continue Reading
Agroz's Big Leap: New Supply Deal in Malaysia

Updated Category News Views 1

Agroz Inc. Executes a Game-Changing Deal If anyone thought the ag tech players were sitting idle, think again. Agroz Inc., noted for their innovative controlled-environment agriculture, just inked a pivotal deal with Harvest Hive in Malaysia. It's not just a nod to expansion—it's a strategic leap into the big leagues. Picture this: Harvest Hive's sprawling 500-acre farm...

Continue Reading
Hanover Unveils Skinny Veg® for GLP-1 Dieters

Updated Category News Views 4

Seems like Hanover Foods is turning heads with their move into the ever-demanding health-conscious market. This family's stepping into the limelight with their new Skinny Veg® line, clearly targeting folks riding the GLP-1 wave. You see, it's not every day that a company that's been around the block since 1924 shakes things up like this. Simplicity is the Name of the...

Continue Reading
Goodwill's ReThink Fashion: Textiles to Runway Art

Updated Category News Views 3

Transforming Old to New on the Runway Right when you think fashion's all about the next shiny thing, here comes Goodwill of Delaware & Delaware County flipping the script. Their ReThink Fashion Show - the ECO Edit teaches us a thing or two about what giving old clothes a new life truly means. It's not just about tossing a used tee onto a catwalk but a whole rebirth...

Continue Reading
ABC Honors 2026 Spirit of the Heart Leaders

Updated Category News Views 2

Celebrating Champions of Cardiovascular Health In a world where accolades often feel as cold as the stock market after a crash, it’s heartening to see genuine recognition for those who are making actual, lasting impact. On October 3, 2026, the Association of Black Cardiologists (ABC) will hold its annual Spirit of the Heart Awards at none other than Cipriani Wall...

Continue Reading
Alif Semiconductor Unveils StartKit for Edge AI MCU Fam

Updated Category News Views 3

Here's some clarity amidst the storm of buzzwords: Alif Semiconductor has rolled out something the market's been howling for—Edge AI that doesn't break the bank. It's less about slick press releases and more about real-world implications. We're talking accessibility with their dirt-cheap, small-form-factor StartKit platform for Ensemble and Balletto microcontrollers....

Continue Reading
RevSystems Joins Elite OpenAI Partner Network

Updated Category News Views 0

RevSystems Inks Deal with OpenAI Partner Network In the latest shuffle of the AI advisory deck, RevSystems just found itself elbowing into the exclusive OpenAI Partner Network. Based out of New York, RevSystems has carved a niche by spinning tech wizardry into tangible business results. Their new status as an OpenAI Select Partner puts them on a playing field where AI...

Continue Reading
MCatalysis Secures $5M to Disrupt Fuel Cost Dynamics

Updated Category News Views 1

Funding Fuels Innovation MCatalysis has just secured a hefty $5 million in seed funding to throw down with the big dogs in energy production. This isn't your regular backyard science project; this company is serious about changing the game with a tech-driven approach that could undercut current fuel prices. HL Energy Ventures and Oxford Science Enterprises are backing...

Continue Reading

Top 5 Most Recently Viewed Articles

Hesai Group Q2 2024 Financial Results Overview

Updated Category News Views 97

Hesai Group Reports Second Quarter 2024 Unaudited Financial Results For the second quarter of 2024, Hesai Group recorded net revenues of RMB458.9 million (US$63.1 million) and shipped a total of 86,526 lidar units. Today, Hesai Group (NASDAQ: HSAI), a global leader in three-dimensional light detection and ranging (lidar) solutions, announced its unaudited financial...

Continue Reading
Optimove's Growth Strategy: Doubling iGaming Clientele Ahead

Updated Category News Views 218

Optimove's Strategy to Expand New iGaming Clients in 2025 Optimove, the pioneering force behind Positionless Marketing and a leader in Player Engagement Platforms for iGaming, is set on a remarkable trajectory towards unprecedented growth. The company recently celebrated significant success, projecting to more than double its base of new iGaming clients in just one year....

Continue Reading
One Liberty Properties Celebrates 132nd Dividend Milestone

Updated Category News Views 154

Celebrating 33 Years of Consistent Dividends One Liberty Properties, Inc. (NYSE: OLP) proudly announces the declaration of a quarterly dividend of $0.45 per share on its common stock. This news is not just a financial update; it marks a significant milestone in the company's history of maintaining dividends, celebrating 33 consecutive years of either increasing or...

Continue Reading
Investors Urged to Act: BioAge Labs Faces Lawsuit Threat

Updated Category News Views 112

Understanding the BioAge Labs Lawsuit Investors in BioAge Labs, Inc. are currently facing a significant legal challenge with a lawsuit that has been initiated against the company and its senior executives. This legal action raises critical concerns about various securities law violations, prompting many investors to seek clarity on their rights and options. If you're...

Continue Reading
Jasper Therapeutics Investors: Join Class Action Lawsuit Today

Updated Category News Views 357

Opportunity for Jasper Therapeutics Investors Investors in Jasper Therapeutics, Inc. are presented with a significant opportunity as a class action lawsuit unfolds concerning potential securities fraud. This class action is spearheaded by Rosen Law Firm, a respected entity in investor rights law, representing those who purchased securities of Jasper Therapeutics, Inc....

Continue Reading